UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 391

Sortiert nach

Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics

Cancer treatment reviews, 2013-11, Vol.39 (7), p.691-700

2013

Volltextzugriff (PDF)

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA

Neoplasia (New York, N.Y.), 2018-07, Vol.20 (7), p.687-696

2018

Volltextzugriff (PDF)

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer

BMC cancer, 2020-09, Vol.20 (1), p.850-850, Article 850

2020

Volltextzugriff (PDF)

Methylated genes as new cancer biomarkers

European journal of cancer (1990), 2009-02, Vol.45 (3), p.335-346

2009

Volltextzugriff (PDF)

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer

Annals of oncology, 2014-11, Vol.25 (11), p.2185-2190

2014

Volltextzugriff (PDF)

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

British journal of cancer, 2010-10, Vol.103 (8), p.1284-1291

2010

Volltextzugriff (PDF)

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer

Scientific reports, 2018-06, Vol.8 (1), p.1-14, Article 9657

2018

Volltextzugriff (PDF)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

Breast cancer research and treatment, 2012-06, Vol.133 (3), p.937-947

2012

Volltextzugriff (PDF)

BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib

British journal of cancer, 2012-09, Vol.107 (6), p.947-955

2012

Volltextzugriff (PDF)

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Annals of oncology, 2015-03, Vol.26 (3), p.510-516

2015

Volltextzugriff (PDF)

Using second harmonic generation to predict patient outcome in solid tumors

BMC cancer, 2015-11, Vol.15 (927), p.929-929, Article 929

2015

Volltextzugriff (PDF)

Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways

Oncogene, 2006-03, Vol.25 (9), p.1413-1419

2006

Volltextzugriff (PDF)

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.387-394

2011

Volltextzugriff (PDF)

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

International journal of cancer, 2015-01, Vol.136 (1), p.91-97

2015

Volltextzugriff (PDF)

A new approach for rapid and reliable enumeration of circulating endothelial cells in patients

Journal of thrombosis and haemostasis, 2012-05, Vol.10 (5), p.931-939

2012

Volltextzugriff (PDF)

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

Cancer research (Chicago, Ill.), 2000-02, Vol.60 (3), p.636-643

2000

Volltextzugriff (PDF)

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

British journal of cancer, 1999-01, Vol.79 (2), p.300-307

1999

Volltextzugriff (PDF)

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3129-3136

1998

Volltextzugriff (PDF)

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

British journal of cancer, 2009-12, Vol.101 (11), p.1824-1832

2009

Volltextzugriff (PDF)

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer

British journal of cancer, 1995-10, Vol.72 (4), p.964-967

1995

Volltextzugriff (PDF)

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

British journal of cancer, 2001-03, Vol.84 (6), p.783-790

2001

Volltextzugriff (PDF)

A Genomic Framework for Precision Radiation Therapy

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S215-S216

2016

Volltextzugriff (PDF)

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (8), p.2155-2162

2000

Volltextzugriff (PDF)

2575 Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S503-S503

2015

Volltextzugriff (PDF)

The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer : a review on 5232 patients

Endocrine reviews, 1992-02, Vol.13 (1), p.3-17

1992

Volltextzugriff (PDF)

1 – 25 von 391

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(376)
Mit Volltextzugriff
(369)

Publikationsform

Artikel
(384)
Tagungsberichte
(7)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer

Methylated genes as new cancer biomarkers

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Using second harmonic generation to predict patient outcome in solid tumors

Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

A new approach for rapid and reliable enumeration of circulating endothelial cells in patients

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

A Genomic Framework for Precision Radiation Therapy

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer

2575 Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer

The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer : a review on 5232 patients

Suchergebnisse filtern